BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2627674)

  • 21. Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledge.
    Wolf DC; Cohen SM; Boobis AR; Dellarco VL; Fenner-Crisp PA; Moretto A; Pastoor TP; Schoeny RS; Seed JG; Doe JE
    Regul Toxicol Pharmacol; 2019 Apr; 103():86-92. PubMed ID: 30634023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
    Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
    Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How well can in vitro data predict in vivo effects of chemicals? Rodent carcinogenicity as a case study.
    Anthony Tony Cox L; Popken DA; Kaplan AM; Plunkett LM; Becker RA
    Regul Toxicol Pharmacol; 2016 Jun; 77():54-64. PubMed ID: 26879462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph Series.
    Bartsch H; Malaveille C
    Cell Biol Toxicol; 1989 Jun; 5(2):115-27. PubMed ID: 2766027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information.
    Lock EA; Hard GC
    Crit Rev Toxicol; 2004; 34(3):211-99. PubMed ID: 15239388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of short-term tests in determining the genotoxicity or nongenotoxicity of chemicals.
    Ashby J
    IARC Sci Publ; 1992; (116):135-64. PubMed ID: 1428079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results.
    Mauthe RJ; Gibson DP; Bunch RT; Custer L
    Toxicol Pathol; 2001; 29 Suppl():138-46. PubMed ID: 11695550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals.
    LeBoeuf RA; Kerckaert GA; Aardema MJ; Gibson DP; Brauninger R; Isfort RJ
    Mutat Res; 1996 Sep; 356(1):85-127. PubMed ID: 8841476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical carcinogenicity revisited 2: Current knowledge of carcinogenesis shows that categorization as a carcinogen or non-carcinogen is not scientifically credible.
    Doe JE; Boobis AR; Dellarco V; Fenner-Crisp PA; Moretto A; Pastoor TP; Schoeny RS; Seed JG; Wolf DC
    Regul Toxicol Pharmacol; 2019 Apr; 103():124-129. PubMed ID: 30660801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
    Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
    IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
    Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
    Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-genotoxic factors in the carcinogenetic process: problems of detection and hazard evaluation.
    Parodi S; Malacarne D; Taningher M
    Toxicol Lett; 1992 Dec; 64-65 Spec No():621-30. PubMed ID: 1471216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The distinct health risk analyses required for genotoxic carcinogens and promoting agents.
    Weisburger JH; Williams GM
    Environ Health Perspect; 1983 Apr; 50():233-45. PubMed ID: 6873017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical carcinogenesis: too many rodent carcinogens.
    Ames BN; Gold LS
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7772-6. PubMed ID: 2217209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro-In Vivo Carcinogenicity.
    Steinberg P
    Adv Biochem Eng Biotechnol; 2017; 157():81-96. PubMed ID: 27506831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic events during the process of cell transformation induced by carcinogens (review).
    Nguyen-Ba G; Vasseur P
    Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.